# Annotation Engine Implementation Status

## Overview
This document tracks the current implementation status of key features in the annotation engine, with special focus on Tumor-Normal vs Tumor-Only workflows, tumor purity integration, and clinical tier assignment.

## Completed Features

### 1. Tumor-Normal vs Tumor-Only Workflow Separation ✅

**Implementation Details:**
- **Analysis Type Detection**: Automatic detection based on VCF inputs
- **Dual VCF Input Support**: `--tumor-vcf` and `--normal-vcf` parameters
- **Legacy Support**: Single VCF input defaults to tumor-only

**Key Components:**
- `models.py`: `AnalysisType` enum (TUMOR_NORMAL, TUMOR_ONLY)
- `vcf_filtering.py`: Separate filter classes for each workflow
  - `TumorNormalFilter`: Direct subtraction approach
  - `TumorOnlyFilter`: Population AF + Panel of Normals filtering
- `variant_processor.py`: Coordinates filtering → annotation pipeline

### 2. Dynamic Somatic Confidence (DSC) Model ✅

**Implementation Details:**
- Replaces flat confidence penalties with sophisticated evidence-based scoring
- Multi-module approach combining:
  1. **VAF/Purity Consistency** - Evaluates expected somatic patterns
  2. **Somatic vs Germline Prior** - Leverages hotspots, population DBs
  3. **Genomic Context** - Placeholder for future LOH/signature analysis

**Key Components:**
- `evidence_aggregator.py`: `DynamicSomaticConfidenceCalculator` class
- `models.py`: `DynamicSomaticConfidence` model
- `tiering.py`: DSC-based tier assignment logic

**Tier Requirements:**
- **Tier I**: DSC > 0.9 (near-certain somatic)
- **Tier II**: DSC > 0.6 (likely somatic)
- **Tier III**: DSC 0.2-0.6 (uncertain)
- **Filtered**: DSC < 0.2 (likely germline)

### 3. Tumor Purity Integration ✅

**Implementation Details:**
- **PURPLE-Inspired VAF-Based Estimation**: Adapted from HMF methodology
- **Multiple Data Sources** (priority order):
  1. HMF PURPLE output files (if available)
  2. User-provided metadata (`--tumor-purity`)
  3. Automatic VAF-based estimation

**Key Components:**
- `purity_estimation.py`: Complete purity estimation module
  - `VAFBasedPurityEstimator`: PURPLE-inspired algorithm
  - `PurityMetadataIntegrator`: Manages multiple purity sources
- `cli.py`: Added `--tumor-purity` and `--purple-output` parameters

**Algorithm Features:**
- Heterozygous peak detection (VAF ≈ purity/2)
- Multiple scenario evaluation (het, LOH, subclonal)
- Quality-based variant filtering
- Confidence scoring for estimates

### 4. Enhanced Tier System with Sub-classifications ✅

**AMP/ASCO/CAP 2017 Tiers Implemented:**
- **Tier IA**: FDA-approved therapies
- **Tier IB**: Professional guidelines
- **Tier IIC**: Clinical evidence (trials, studies)
- **Tier IID**: Preclinical evidence
- **Tier IIE**: Investigational/Emerging Evidence
- **Tier III**: VUS
- **Tier IV**: Benign/Likely Benign

**Key Components:**
- `models.py`: `AMPTierLevel` enum with all sub-classifications
- `tiering.py`: Context-specific tier assignment logic

### 5. VICC/CGC 2022 Evidence Codes ✅

**Implemented Evidence Codes:**
- **Very Strong (8 points)**: OVS1
- **Strong (4 points)**: OS1, OS2, OS3
- **Moderate (2 points)**: OM1, OM2, OM3, OM4
- **Supporting (1 point)**: OP1, OP2, OP3, OP4
- **Benign (negative)**: SBVS1, SBS1, SBS2, SBP1

**Key Components:**
- `models.py`: `VICCScoring` model with all evidence codes
- `evidence_aggregator.py`: Evidence code assignment logic

### 6. Clinical Reporting Features ✅

**Canned Text Generation:**
- Nine standardized text types implemented
- Dynamic text based on DSC scores
- Mandatory disclaimers for tumor-only analysis

**Key Components:**
- `tiering.py`: `CannedTextGenerator` class
- `models.py`: `CannedText` and `CannedTextType` enums

## Testing Coverage

### Completed Test Suites:
1. **Purity Integration Tests** (`test_purity_integration.py`)
   - VAF-based estimation scenarios
   - Metadata integration
   - PURPLE output parsing
   - DSC integration with purity

2. **DSC Calculation Tests** (`test_dsc_calculation.py`)
   - High/moderate/low confidence scenarios
   - Tier requirement validation
   - Edge cases and missing data

3. **Tier Assignment Tests** (`test_tier_assignment.py`)
   - Multi-context tier assignment
   - DSC-based tier modulation
   - Evidence integration

## Configuration & Metadata

### CLI Parameters Added:
- `--tumor-vcf` / `--normal-vcf`: Dual VCF input
- `--tumor-purity`: Direct purity input (0.0-1.0)
- `--purple-output`: Path to HMF PURPLE results

### Validation Schemas Updated:
- `input_schemas.py`: Added purity fields with proper validation
- Support for analysis type detection

## Documentation

### Updated Documents:
- **README.md**: Comprehensive workflow documentation
- **TN_VERSUS_TO.md**: Complete DSC model specification
- **ANNOTATION_BLUEPRINT.md**: Tier sub-classification details
- **CLAUDE.md**: Development guidelines

## Integration Notes

### HMF Tools Integration:
- **Not a Direct Dependency**: No HMF tools installation required
- **PURPLE-Inspired**: Adapted concepts, not direct code usage
- **Optional Integration**: Can read PURPLE output if available

### Key Design Decisions:
1. **Modular Architecture**: Each component (filtering, purity, DSC) is independent
2. **Graceful Degradation**: Works without purity data (automatic estimation)
3. **Clinical Safety**: Mandatory disclaimers for tumor-only analysis
4. **Evidence-Based**: All confidence modulations based on specific evidence

## Next Steps

### Pending Implementation:
1. **VEP Integration**: Connect to actual VEP runner
2. **Knowledge Base Loading**: Complete KB aggregator implementation
3. **End-to-End Pipeline**: Wire all components together
4. **Production Testing**: Real VCF files with clinical validation

### Future Enhancements:
1. **LOH Detection**: For genomic context module
2. **Mutational Signatures**: Additional somatic evidence
3. **Panel of Normals**: Production PoN integration
4. **CNV Integration**: Copy number for purity refinement